Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Amyloid Angiopathy | 8 | 2024 | 887 | 2.290 |
Why?
|
Siderosis | 3 | 2023 | 100 | 2.160 |
Why?
|
Cerebral Hemorrhage | 11 | 2025 | 2654 | 1.890 |
Why?
|
Endocarditis | 3 | 2022 | 352 | 1.770 |
Why?
|
Endocarditis, Bacterial | 2 | 2022 | 436 | 1.200 |
Why?
|
Status Epilepticus | 3 | 2020 | 459 | 0.970 |
Why?
|
Stroke | 10 | 2024 | 9744 | 0.970 |
Why?
|
Pneumocephalus | 1 | 2024 | 46 | 0.870 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2024 | 277 | 0.820 |
Why?
|
Cerebrovascular Trauma | 1 | 2022 | 21 | 0.820 |
Why?
|
Aneurysm, Infected | 1 | 2022 | 82 | 0.770 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1659 | 0.760 |
Why?
|
Hypertension | 5 | 2025 | 8616 | 0.730 |
Why?
|
Vascular System Injuries | 1 | 2022 | 247 | 0.640 |
Why?
|
Intracranial Embolism | 1 | 2020 | 188 | 0.620 |
Why?
|
Meningitis, Aseptic | 1 | 2018 | 59 | 0.620 |
Why?
|
Sweet Syndrome | 1 | 2018 | 56 | 0.600 |
Why?
|
Prions | 2 | 2016 | 177 | 0.580 |
Why?
|
Vasospasm, Intracranial | 1 | 2018 | 207 | 0.510 |
Why?
|
Hyperglycemia | 1 | 2024 | 1389 | 0.510 |
Why?
|
Anesthetics, Intravenous | 1 | 2018 | 396 | 0.500 |
Why?
|
Meningioma | 1 | 2024 | 1221 | 0.480 |
Why?
|
Moyamoya Disease | 1 | 2018 | 274 | 0.470 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1255 | 0.470 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1029 | 0.470 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2014 | 17 | 0.470 |
Why?
|
Brain Waves | 1 | 2018 | 416 | 0.460 |
Why?
|
Staphylococcal Infections | 1 | 2022 | 1396 | 0.430 |
Why?
|
Brain Diseases | 1 | 2022 | 1552 | 0.420 |
Why?
|
Thrombectomy | 6 | 2024 | 676 | 0.390 |
Why?
|
Anesthesia, General | 1 | 2018 | 1188 | 0.380 |
Why?
|
Brain Injuries | 1 | 2022 | 2053 | 0.360 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1193 | 0.350 |
Why?
|
Magnetic Resonance Imaging | 12 | 2025 | 36570 | 0.350 |
Why?
|
Muscle Proteins | 1 | 2014 | 1160 | 0.320 |
Why?
|
Brain Infarction | 2 | 2021 | 285 | 0.310 |
Why?
|
Cerebral Infarction | 3 | 2022 | 968 | 0.300 |
Why?
|
Endovascular Procedures | 5 | 2024 | 2215 | 0.300 |
Why?
|
Leukoencephalopathies | 2 | 2022 | 258 | 0.300 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3683 | 0.270 |
Why?
|
Critical Care | 1 | 2018 | 2714 | 0.260 |
Why?
|
Administration, Oral | 2 | 2023 | 4019 | 0.240 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5182 | 0.230 |
Why?
|
Cerebrovascular Circulation | 3 | 2024 | 2671 | 0.230 |
Why?
|
Brain Ischemia | 3 | 2022 | 3001 | 0.230 |
Why?
|
Humans | 39 | 2025 | 766812 | 0.220 |
Why?
|
Middle Aged | 20 | 2025 | 223267 | 0.220 |
Why?
|
Retrospective Studies | 14 | 2025 | 81657 | 0.210 |
Why?
|
Cerebellar Diseases | 1 | 2025 | 227 | 0.200 |
Why?
|
Cerebral Ventricles | 1 | 2024 | 550 | 0.200 |
Why?
|
Reflex | 1 | 2024 | 375 | 0.200 |
Why?
|
Aged, 80 and over | 8 | 2025 | 59548 | 0.200 |
Why?
|
Aged | 18 | 2025 | 171344 | 0.200 |
Why?
|
Infarction | 1 | 2022 | 247 | 0.180 |
Why?
|
Leukoaraiosis | 1 | 2022 | 114 | 0.180 |
Why?
|
Coma | 1 | 2024 | 485 | 0.170 |
Why?
|
Male | 19 | 2025 | 364154 | 0.160 |
Why?
|
Female | 21 | 2025 | 396532 | 0.160 |
Why?
|
Intracranial Hemorrhages | 2 | 2022 | 810 | 0.160 |
Why?
|
Brain Edema | 1 | 2023 | 601 | 0.160 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 856 | 0.150 |
Why?
|
Blood Coagulation Factors | 1 | 2020 | 371 | 0.150 |
Why?
|
Corpus Callosum | 1 | 2022 | 751 | 0.140 |
Why?
|
Nephritis, Interstitial | 1 | 2018 | 157 | 0.140 |
Why?
|
Cerebellum | 1 | 2025 | 1520 | 0.140 |
Why?
|
Heart Atria | 1 | 2023 | 1362 | 0.140 |
Why?
|
Anticoagulants | 2 | 2023 | 4854 | 0.140 |
Why?
|
Polycythemia Vera | 1 | 2018 | 160 | 0.140 |
Why?
|
Cerebral Arteries | 1 | 2019 | 490 | 0.140 |
Why?
|
Uveitis | 1 | 2018 | 398 | 0.120 |
Why?
|
Ischemic Attack, Transient | 1 | 2020 | 874 | 0.120 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2030 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 877 | 0.110 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1263 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2028 | 0.100 |
Why?
|
Recurrence | 2 | 2020 | 8507 | 0.090 |
Why?
|
Blood Glucose | 1 | 2024 | 6422 | 0.090 |
Why?
|
Mutation | 1 | 2014 | 30214 | 0.080 |
Why?
|
Reperfusion | 2 | 2020 | 268 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2014 | 581 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14653 | 0.080 |
Why?
|
Reperfusion Injury | 1 | 2015 | 1043 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3250 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2023 | 65286 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8533 | 0.080 |
Why?
|
Acute Disease | 1 | 2018 | 7240 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4215 | 0.070 |
Why?
|
Risk Factors | 4 | 2022 | 74889 | 0.070 |
Why?
|
Electroencephalography | 2 | 2020 | 6282 | 0.070 |
Why?
|
Cohort Studies | 3 | 2024 | 41706 | 0.070 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15912 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10580 | 0.060 |
Why?
|
Adult | 4 | 2024 | 223305 | 0.060 |
Why?
|
Laryngeal Muscles | 1 | 2024 | 107 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12985 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39312 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29959 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15831 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 151 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2024 | 1374 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7073 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2024 | 1138 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2021 | 2809 | 0.040 |
Why?
|
Factor Xa | 1 | 2020 | 165 | 0.040 |
Why?
|
Electromyography | 1 | 2024 | 1398 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2024 | 1478 | 0.030 |
Why?
|
Infant | 2 | 2021 | 36459 | 0.030 |
Why?
|
History, 19th Century | 1 | 2019 | 714 | 0.030 |
Why?
|
Amyloid | 1 | 2022 | 849 | 0.030 |
Why?
|
Arterial Occlusive Diseases | 1 | 2020 | 742 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2022 | 1079 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6548 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 818 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2353 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15425 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2015 | 364 | 0.030 |
Why?
|
History, 21st Century | 1 | 2019 | 1574 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 616 | 0.030 |
Why?
|
Brain | 1 | 2019 | 27158 | 0.020 |
Why?
|
Young Adult | 1 | 2018 | 59939 | 0.020 |
Why?
|
History, 20th Century | 1 | 2019 | 2764 | 0.020 |
Why?
|
Tyrosine | 1 | 2015 | 1425 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6507 | 0.020 |
Why?
|
Animals | 3 | 2019 | 168939 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2030 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40149 | 0.020 |
Why?
|
Seizures | 1 | 2020 | 2996 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6779 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20146 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 8065 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2015 | 2101 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2015 | 3139 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15835 | 0.010 |
Why?
|
Mitochondria | 1 | 2015 | 3678 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16722 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10863 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20710 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14473 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24299 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18076 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54872 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81898 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_